Stockscreener 앱 받기
7.21
2.96%
-0.22
시간 외 거래:
7.21
전일 마감가:
$7.43
열려 있는:
$7.41
하루 거래량:
732.66K
Relative Volume:
0.76
시가총액:
$1.10B
수익:
$43.34M
순이익/손실:
$-247.99M
주가수익비율:
-3.6529
EPS:
-1.9738
순현금흐름:
$-224.28M
1주 성능:
-6.73%
1개월 성능:
-17.97%
6개월 성능:
-30.87%
1년 성능:
-30.41%
1일 변동 폭
$7.14
$7.42
1주일 범위
$7.02
$7.81
52주 변동 폭
$7.02
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, MRNA, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
7.21 | 1.10B | 43.34M | -247.99M | -224.28M | -1.9738 |
VRTX
Vertex Pharmaceuticals Inc
|
507.00 | 128.50B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
213.74 | 85.33B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
762.81 | 78.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
812.30 | 51.08B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.95 | 41.57B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-28 | 개시 | TD Cowen | Buy |
| 2026-03-16 | 재개 | Jefferies | Buy |
| 2025-09-18 | 개시 | Guggenheim | Buy |
| 2025-05-28 | 개시 | Deutsche Bank | Buy |
| 2024-10-07 | 개시 | Piper Sandler | Overweight |
| 2023-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-31 | 개시 | Mizuho | Buy |
| 2023-03-24 | 개시 | Bryan Garnier | Buy |
| 2020-11-20 | 개시 | BofA Securities | Buy |
| 2020-09-22 | 개시 | Goldman | Buy |
| 2020-07-27 | 개시 | SVB Leerink | Outperform |
| 2020-07-24 | 개시 | Jefferies | Buy |
모두보기
Immatics N V 주식(IMTX)의 최신 뉴스
Immatics (IMTX) Slips 3.23% to $7.19 as Shares Drift Toward Lower SupportTotal Put Call - www.dars.gov.et
Immatics (NASDAQ:IMTX) Reaches New 1-Year LowHere's Why - MarketBeat
Immatics (IMTX) Slides 10% as Shares Test Key Support Near $7.21Chaikin Flow - siam.in
Immatics (NASDAQ:IMTX) Sets New 52-Week LowHere's What Happened - MarketBeat
Immatics (NASDAQ:IMTX) Shares Down 5.3%Here's What Happened - marketbeat.com
Immatics (Nasdaq:IMTX)Stock Analysis - Simply Wall Street
Immatics (NASDAQ:IMTX) Sees Unusually-High Trading VolumeStill a Buy? - marketbeat.com
Immatics (NASDAQ:IMTX) Stock Rating Upgraded by Wall Street Zen - marketbeat.com
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeWhat's Next? - marketbeat.com
Immatics stock falls 3.04 percent after cash raise and Q2 miss - AD HOC NEWS
Immatics N.V. (NASDAQ:IMTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Price-Driven Insight from (IMTX) for Rule-Based Strategy - Stock Traders Daily
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportShort Term Trading Ideas - vinanet.vn
Immatics stock holds near USD 9.60 after market cap update - ad-hoc-news.de
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportHigh Reward Trades - dars.gov.et
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportUnusual Put Volume - www.dars.gov.et
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportInsider Selling Alerts - www.dars.gov.et
Immatics N.V. Warrants (IMTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Immatics (NASDAQ:IMTX) Shares Up 5.3% on Insider Buying Activity - MarketBeat
Insider Buying: Immatics (NASDAQ:IMTX) Director Purchases 863,060 Shares of Stock - MarketBeat
Perceptive fund boosts Immatics (IMTX) stake with new open-market share buy - Stock Titan
Perceptive Advisors Acquires 863,060 Shares of Immatics N.V. at $8.69 Each - Kalkine Media
Immatics (NASDAQ: IMTX) gets 863K-share buy at $8.69 from Perceptive - Stock Titan
Trading Systems Reacting to (IMTX) Volatility - Stock Traders Daily
Immatics (NASDAQ: IMTX) raises fresh cash to fund oncology pipeline - Stock Titan
Form 424B2 Immatics N.V. - StreetInsider
Why is Immatics stock climbing today? - Investing.com India
Why is Immatics stock climbing today? By Investing.com - Investing.com Nigeria
Why is Immatics stock climbing today? By Investing.com - Investing.com UK
Immatics Announces $150 Million Underwritten Offering - Yahoo Finance
Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma - Seeking Alpha
Immatics Announces $150 Million Underwritten Offering - GlobeNewswire
Immatics Announces $150 Million Underwritten Offering - Yahoo Finance
Why Immatics (IMTX) Is Down 5.4% After Mixed First‑Half 2026 Loss Trends And What's Next - simplywall.st
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
James Nelson Pepin Net Worth (2026) - GuruFocus
Immatics (NASDAQ:IMTX) Shares Down 8%Should You Sell? - MarketBeat
Immatics Announces Second Quarter 2026 Financial Results and Business Update - Sahm
Immatics (IMTX) awards counsel Nelson 225K share package - Stock Titan
Immatics Releases Q2 2026 Financial Results - AlphaStreet
Immatics Q2 revenue rises to $10.4 million - grafa.com
Immatics earnings on deck as analysts eye revenue trajectory By Investing.com - Investing.com India
Immatics earnings on deck as analysts eye revenue trajectory - Investing.com
Immatics earnings on deck as analysts eye revenue trajectory - Investing.com
Immatics Q2 Results: EPS misses estimate, sales up 93% YoY - scanx.trade
IMTX Looks 176.9% Overvalued on GF Value™ - GuruFocus
Immatics (NASDAQ:IMTX) Issues Earnings Results - MarketBeat
Immatics (IMTX) Slides 2.01% as Shares Approach Key $8.79 Support LevelQuality Factor - Vinanet
Immatics Posts Interim Q2 2026 Results and Updates Investor Materials - TipRanks
Immatics' Q2 Net Loss Narrows as Revenue Rises - marketscreener.com
Immatics N V (IMTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.73%
0.12%
자본화:
|
볼륨(24시간):